NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday

Raymond James boosted the price target for Jabil Inc. JBL from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on Thursday.
Keybanc cut the price target for LyondellBasell Industries N.V. LYB from $84 to $81. Keybanc analyst Aleksey Yefremov maintained an Underweight rating. LyondellBasell shares rose 1.6% to close at $91.77 on Thursday.
JP Morgan slashed the price target for Mersana Therapeutics, Inc. MRSN from $11 to $5. JP Morgan analyst Brian Cheng downgraded the stock from Overweight to Neutral. Mersana Therapeutics shares fell 0.3% to $3.88 in pre-market trading.
Piper Sandler boosted Adobe Inc. ADBE price target from $500 to $572. Piper Sandler analyst Brent Bracelin maintained an Overweight rating. Adobe shares rose 2.4% to close at $490.91 on Thursday.
Truist Securities lowered Extra Space Storage Inc. EXR price target from $165 to $155. Truist Securities analyst Ki Bin Kim maintained a Hold rating. Extra Space Storage shares rose 2.9% to $149.95 in pre-market trading.
UBS boosted AutoZone, Inc. AZO price target from $2,800 to $2,900. UBS analyst Michael Lasser upgraded the stock from Neutral to Buy. AutoZone shares rose 4.1% to close at $2,497.37 on Thursday.
Needham increased Clearfield, Inc. CLFD price target from $50 to $60. Needham analyst Ryan Koontz maintained a Buy rating. Clearfield shares rose 1% to $47.20 in pre-market trading.
Rosenblatt raised the price target for Zscaler, Inc. ZS from $165 to $185. Rosenblatt analyst Catharine Trebnick maintained a Buy rating. Zscaler shares rose 0.7% to $159.40 in pre-market trading.
Morgan Stanley increased NVIDIA Corporation NVDA price target from $450 to $500. Morgan Stanley analyst Joseph Moore maintained an Overweight rating. NVIDIA shares fell 0.8% to close at $426.53 on Thursday.
B of A Securities raised West Pharmaceutical Services, Inc. WST price target from $390 to $405. B of A Securities analyst Derik De Bruin upgraded the stock from Neutral to Buy. West Pharmaceutical Services shares rose 0.8% to $362.65 in pre-market trading.
Citigroup cut RPC, Inc. RES price target from $8.25 to $7. Citigroup analyst Scott Gruber downgraded the stock from Neutral to Sell. RPC shares fell 2.3% to $7.63 in pre-market trading.